Bifidobacterium breve Bif195 Protects Against Small-intesti…

A CCEPTED MANUSCRIPT

Supplementary table 1. Trial product composition

Placebo capsules

Probiotic capsules Bifidobacterium breve

Manufacturing

Chr. Hansen A/S, Denmark Chr. Hansen A/S, Denmark

Brief description

Capsules with excipients only

Capsules containing Bifidobacterium breve and excipients

Capsules

Size 1 HPMC capsules

Size 1 HPMC capsules

Capsules shell

73.6 mg Hypmellose 1.4 mg Titanium dioxide

73.6 mg Hypmellose 1.4 mg Titanium dioxide

Active Ingredients None

Bifidobacterium breve Bif195

Excipients

Microcrystalline Cellulose 6 mg per capsule Magnesium Stearate 1.5 mg per capsule Maltodextrin 277.8 mg per capsule Sodium Ascorbate 14.7 mg per capsule

Supplied as

CSP Activ-Vials containing 24 capsules in each vial

Storage conditions Store at +2-8 ºC

MANUSCRIPT

1

Powered by